Research Article
BibTex RIS Cite

Pediatric Rhinosinusitis: Its Predisposing Factors and Management

Year 2024, Volume: 7 Issue: 2 , 67 - 71 , 20.08.2024
https://izlik.org/JA38AY75DC

Abstract

Objective: Rhinosinusitis is a prevalent disease in children that can cause many substantial physical symptoms and have a detrimental influence on their quality of life. This study aims to evaluate the predisposing factors, and management of pediatric rhinosinusitis patients.

Methods: A cross-sectional study using retrospective data from 324 pediatric rhinosinusitis patients was conducted. Demographics, predisposing factors, and management were recorded.

Results: Many of the affected patients (50.3%) were between 6 and 11 years old. The predisposing factors were allergic rhinitis (97.2%), asthma (27.2%), upper respiratory tract infection (24.4%), adenoid hypertrophy (17.9%), and gastro-oesophageal reflux disease (0.6%). A significant association was found between the age group with upper respiratory infection as a predisposing factor in pediatric rhinosinusitis (P-value .000). Most of our patients (99.7%) responded well to medical treatment, and 8.6% of them underwent surgical therapy, mainly adenotonsillectomy.

Conclusion: This study demonstrated that allergic rhinitis was the most established predisposing factor for pediatric rhinosinusitis, followed by asthma, upper respiratory tract infection, and adenoid hypertrophy. Medical therapy was the mainstay of treatment for pediatric rhinosinusitis patients.

References

  • Leo G, Incorvaia C, Cazzavillan A, Consonni D. May chronic rhinosinusitis in children be diagnosed by clinical symptoms? Int J Pediatr Otorhinolaryngol. 2015;79(6):825-828.
  • Ramadan HH. Chronic rhinosinusitis in children. Int J Pediatr. 2012;2012:573942.
  • Fokkens WJ, Lund VJ, Hopkins C, et al. Executive summary of EPOS 2020 including integrated care pathways. Rhinology. 2020;58(2):82-111.
  • Quintanilla-Dieck L, Lam DJ. Chronic rhinosinusitis in children. Curr Treat Options Pediatr. 2018;4(4):413-424.
  • Ramadan HH, Chaiban R, Makary C. Pediatric rhinosinusitis. Pediatr Clin North Am. 2022;69(2):275-286.
  • Badr DT, Gaffin JM, Phipatanakul W. Pediatric rhinosinusitis. Curr Treat Options Allergy. 2016;3(3):268-281.
  • Otto WR, Paden WZ, Connors M, et al. Suppurative intracranial complications of pediatric sinusitis: a single-center experience. J Pediatr Infect Dis Soc. 2021;10(3):309-316.
  • Shahid SK. Rhinosinusitis in children. ISRN Otolaryngol. 2012;2012:851831.
  • Siddiqui Z, Tahiri M, Gupta A, Kin Nam RH, Rachmanidou A. The management of paediatric rhinosinusitis. Int J Pediatr Orl. 2021;147:110786.
  • Kim NN, Marikar D. Antibiotic prescribing for upper respiratory tract infections: NICE guidelines. Arch Dis Child Educ Pract Ed. 2020;105(2):104-106.
  • Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl S29):1-464.
  • Orb Q, Curtin K, Oakley GM, et al. Familial risk of pediatric chronic rhinosinusitis. Laryngoscope. 2016;126(3):739-745.
  • Sedaghat AR, Phipatanakul W, Cunningham MJ. Prevalence of and associations with allergic rhinitis in children with chronic rhinosinusitis. Int J Pediatr Orl. 2014;78(2):343-347.
  • Marom T, Alvarez-Fernandez PE, Jennings K, Patel JA, McCormick DP, Chonmaitree T. Acute bacterial sinusitis complicating viral upper respiratory tract infection in young children. Pediatr Infect Dis J. 2014 ;33(8):803-808.
  • DeMuri GP, Eickhoff JC, Gern JC, Wald ER. Clinical and virological characteristics of acute sinusitis in children. Clin Infect Dis. 2019;69(10):1764-1770.
  • Poddighe D, Brambilla I, Licari A, Marseglia GL. Pediatric rhinosinusitis and asthma. Respir Med. 2018;141:94-99.
  • Vujnovic SD, Domuz A. Epidemiological aspects of rhinitis and asthma: comorbidity or united airway disease [Internet]. Asthma Diagnosis and Management - Approach Based on Phenotype and Endotype. InTech. 2018.
  • Chang CC. Sinusitis, rhinitis, asthma, and the single airway hypothesis. Dis Sinuses. 2013;5:173-194.
  • Fuller CG, Schoettler JJ, Gilsanz V, Nelson MD, Church JA, Richards W. Sinusitis in status asthmaticus. Clin Pediatr. 1994;33(12):712-719.
  • Giavina-Bianchi P, Aun MV, Takejima P, Kalil J, Agondi RC. United airway disease: current perspectives. J Asthma Allergy. 2016;9:93-100.
  • Ramaswamy US, Patel VA, Lee SE. Managing chronic rhinosinusitis in severe asthma. Curr Opin Pulm Med. 2021;27(1):23-28.
  • Belcher R, Virgin F. The role of the adenoids in pediatric chronic rhinosinusitis. Med Sci (Basel). 2019;7(2):35.
  • Shin KS, Cho SH, Kim KR, et al. The role of adenoids in pediatric rhinosinusitis. Int J Pediatr Orl. 2008;72(11):1643-1650.
  • Nation J, Kaufman M, Allen M, Sheyn A, Coticchia J. Incidence of gastroesophageal reflux disease and positive maxillary antral cultures in children with symptoms of chronic rhinosinusitis. Int J Pediatr Orl. 2014;78(2):218-222.
  • Beatrice M, John A, Ahmed L, Peter M. Prevalence of chronic rhinosinusitis in children with dyspepsia–A cross sectional study. Egypt J Ear Nose Throat Allied Sci. 2016;17(3):139-142.
  • Goh YY, Keshavarzi F, Chew YL. Prevalence of atopic dermatitis and pattern of drug therapy in Malaysian children. Dermatitis. 2018;29(3):151-161.
  • Simpson EL. Comorbidity in atopic dermatitis. Curr Dermatol Rep. 2012;1(1):29-38.
  • Paller AS, Mina-Osorio P, Vekeman F, et al. Prevalence of type 2 inflammatory diseases in pediatric patients with atopic dermatitis: Real-world evidence. J Am Acad Dermatol. 2022;86(4):758-765.
  • Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev. 2007;3(3):CD006394.
  • Vasco CTC, Morais HC, Avelino MAG. Systematic review of the literature on surgical treatment of chronic rhinosinusitis in children: what is the best approach? Rev Paul Pediatr. 2020;38:e2018068.
There are 30 citations in total.

Details

Primary Language English
Subjects Otorhinolaryngology
Journal Section Research Article
Authors

Sethu Thakachy Subha This is me 0000-0002-2156-9840

Submission Date June 24, 2024
Acceptance Date August 2, 2024
Publication Date August 20, 2024
DOI https://doi.org/10.5152/ejra.2024.24143
IZ https://izlik.org/JA38AY75DC
Published in Issue Year 2024 Volume: 7 Issue: 2

Cite

APA Subha, S. T. (2024). Pediatric Rhinosinusitis: Its Predisposing Factors and Management. European Journal of Rhinology and Allergy, 7(2), 67-71. https://doi.org/10.5152/ejra.2024.24143
AMA 1.Subha ST. Pediatric Rhinosinusitis: Its Predisposing Factors and Management. Eur J Rhinol Allergy. 2024;7(2):67-71. doi:10.5152/ejra.2024.24143
Chicago Subha, Sethu Thakachy. 2024. “Pediatric Rhinosinusitis: Its Predisposing Factors and Management”. European Journal of Rhinology and Allergy 7 (2): 67-71. https://doi.org/10.5152/ejra.2024.24143.
EndNote Subha ST (August 1, 2024) Pediatric Rhinosinusitis: Its Predisposing Factors and Management. European Journal of Rhinology and Allergy 7 2 67–71.
IEEE [1]S. T. Subha, “Pediatric Rhinosinusitis: Its Predisposing Factors and Management”, Eur J Rhinol Allergy, vol. 7, no. 2, pp. 67–71, Aug. 2024, doi: 10.5152/ejra.2024.24143.
ISNAD Subha, Sethu Thakachy. “Pediatric Rhinosinusitis: Its Predisposing Factors and Management”. European Journal of Rhinology and Allergy 7/2 (August 1, 2024): 67-71. https://doi.org/10.5152/ejra.2024.24143.
JAMA 1.Subha ST. Pediatric Rhinosinusitis: Its Predisposing Factors and Management. Eur J Rhinol Allergy. 2024;7:67–71.
MLA Subha, Sethu Thakachy. “Pediatric Rhinosinusitis: Its Predisposing Factors and Management”. European Journal of Rhinology and Allergy, vol. 7, no. 2, Aug. 2024, pp. 67-71, doi:10.5152/ejra.2024.24143.
Vancouver 1.Sethu Thakachy Subha. Pediatric Rhinosinusitis: Its Predisposing Factors and Management. Eur J Rhinol Allergy. 2024 Aug. 1;7(2):67-71. doi:10.5152/ejra.2024.24143

You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104

Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.